In the near future, clinical trials will use machine learning routinely to analyze data. Today, however, machine learning is still at an adoption midpoint—no longer pioneering, but not yet ubiquitous.
After five decades of use, flow cytometry is entrenched in biomedical science. Besides enabling the quick processing of cells in suspension, flow cytometry provides quantitative results across ...